(Q37933582)

25 August 2017

1 reference

title

The coronary circulation and blood flow in left ventricular hypertrophy (English)

1 reference

25 August 2017

Paolo G Camici

1

1 reference

25 August 2017

Iacopo Olivotto

series ordinal

2

1 reference

25 August 2017

Ornella E Rimoldi

series ordinal

3

1 reference

25 August 2017

language of work or name

1 reference

5 September 2011

1 reference

Journal of Molecular and Cellular Cardiology

25 August 2017

published in

1 reference

25 August 2017

volume

52

1 reference

25 August 2017

issue

4

1 reference

25 August 2017

page(s)

857-864

1 reference

Left ventricular hypertrophy. Relation of structure to diastolic function in hypertension

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Fibrosis and hypertensive heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Myocardial remodeling: cellular and extracellular events and targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

The hypertensive heart. An integrated understanding informed by imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Coronary microvascular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy. A study with positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Adenosine and maximum coronary vasodilation in humans: myth and misconceptions in the assessment of coronary reserve

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Relation between Myocardial Blood Flow and the Severity of Coronary-Artery Stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Augmented alpha-adrenergic constriction of atherosclerotic human coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

The clinical value of myocardial blood flow measurement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Measurement of absolute myocardial blood flow with H215O and dynamic positron-emission tomography. Strategy for quantification in relation to the partial-volume effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Regional myocardial perfusion assessed with N-13 labeled ammonia and positron emission computerized axial tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Noninvasive quantification of regional myocardial perfusion with rubidium-82 and positron emission tomography. Exploration of a mathematical model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Reproducibility and accuracy of quantitative myocardial blood flow assessment with (82)Rb PET: comparison with (13)N-ammonia PET.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Enhancement of regional myocardial efficiency and persistence of perfusion, oxidative, and functional reserve with paired pacing of stunned myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Measurement of myocardial blood flow with oxygen-15 labelled water: comparison of different administration protocols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Hypertrophic cardiomyopathy: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the Euro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Inherited Cardiomyopathies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Developmental origins of hypertrophic cardiomyopathy phenotypes: a unifying hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Isolated ventricular noncompaction is associated with coronary microcirculatory dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with alpha galactosidase A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

The many faces of hypertrophic cardiomyopathy: from developmental biology to clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Alterations of the architecture of subendocardial arterioles in patients with hypertrophic cardiomyopathy and impaired coronary vasodilator reserve: a possible cause for myocardial ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

The case for myocardial ischemia in hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Differences in coronary flow and myocardial metabolism at rest and during pacing between patients with obstructive and patients with nonobstructive hypertrophic cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Effect of verapamil on absolute myocardial blood flow in hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Effect of successful alcohol septal ablation on microvascular function in patients with obstructive hypertrophic cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Regional myocardial ischemia in hypertrophic cardiomyopathy: impact of myectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Spatial relationship between coronary microvascular dysfunction and delayed contrast enhancement in patients with hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Regional heterogeneity of resting perfusion in hypertrophic cardiomyopathy is related to delayed contrast enhancement but not to systolic function: a PET and MRI study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Microvascular Function Is Selectively Impaired in Patients With Hypertrophic Cardiomyopathy and Sarcomere Myofilament Gene Mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Narrative review: Fabry disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Physiologic left ventricular cavity dilatation in elite athletes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Remodeling of left ventricular hypertrophy in elite athletes after long-term deconditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Myocardial late gadolinium enhancement: prevalence, pattern, and prognostic relevance in marathon runners.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Left ventricular volumes and mass in marathon runners and their association with cardiovascular risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Comparison of coronary vasodilator reserve in elite rowing athletes versus hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Exercise training in swine promotes growth of arteriolar bed and capillary angiogenesis in heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Cardiac hypertrophy and thyroid hormone signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Thyroid hormone and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Coronary microvasculature alteration in hypertensive rats. Effect of treatment with a diuretic and an ACE inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Response of the coronary vasculature to myocardial hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Morphometric investigation of human myocardium in arterial hypertension and valvular aortic stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Remodelling of intramyocardial arterioles and extracellular matrix in patients with arterial hypertension and impaired coronary reserve

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Positron emission tomography, echo-doppler, and exercise studies of functional capacity in hypertensive heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Perindopril and indapamide reverse coronary microvascular remodelling and improve flow in arterial hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Association between vascular dysfunction and reduced myocardial flow reserve in patients with hypertension: a LIFE substudy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Impairment of Flow-Dependent Coronary Dilation in Hypertensive Patients Demonstration by Cold Pressor Test Induced Flow Velocity Increase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Olmesartan, but not amlodipine, improves endothelium-dependent coronary dilation in hypertensive patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Myocardial perfusion during long-term angiotensin-converting enzyme inhibition or beta-blockade in patients with essential hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Fibrosis and ischemia: the real risks in hypertensive heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Natural history of very severe aortic stenosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Impaired coronary and myocardial flow in severe aortic stenosis is associated with increased apoptosis: a transthoracic Doppler and myocardial contrast echocardiography study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Alterations in multidirectional myocardial functions in patients with aortic stenosis and preserved ejection fraction: a two-dimensional speckle tracking analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Clinical practice. Aortic stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Impairment of coronary flow reserve in aortic stenosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Functional changes in coronary microcirculation after valve replacement in patients with aortic stenosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Myocardial blood flow in patients with low-flow, low-gradient aortic stenosis: differences between true and pseudo-severe aortic stenosis. Results from the multicentre TOPAS (Truly or Pseudo-Severe Aortic Stenosis) study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

Hemodynamic mechanisms responsible for reduced subendocardial coronary reserve in dogs with severe left ventricular hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.028

10.1016/J.YJMCC.2011.08.028

7 January 2021

Identifiers

DOI

1 reference

25 August 2017

1 reference